Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Omary Hassan
Institution:
Ifakara Health Institute
Observed institution:
Ifakara Health Institute
ORCID:
0000-0002-3930-7101
Observed ORCID:
0000-0002-3930-7101
OpenAlex ID:
A5035365115
Safety and Tolerability of an Antimalarial Herbal Remedy in Healthy Volunteers: An Open-Label, Single-Arm, Dose-Escalation Study on Maytenus senegalensis in Tanzania
2022
·
Kamaka Kassimu
, Florence Milando
, et al.
·
Tropical Medicine and Infectious Disease
·
10
PDF
Safety and immunogenicity of a single-dose adenovirus-vectored rabies vaccine over 1 year in adults and children in Tanzania: interim data from an ongoing, partly randomised, controlled, phase 1b/2 trial
2026
·
Adam J Ritchie
, Omary Hassan
, et al.
·
The Lancet Infectious Diseases
·
3
Full-length merozoite surface protein 1 formulated with GLA-SE adjuvant in malaria pre-exposed adults: a randomised, controlled, double-blind, parallel-group, single-centre Phase Ib trial
2025
·
Aina-ekisha Kahatano
, Maxmillian Mpina
, et al.
·
EClinicalMedicine
·
2
Establishing a blood-stage controlled human malaria infection model with Plasmodium falciparum in healthy semi-immune Tanzanian adults
2026
·
Sarah E. Silk
, Jo Salkeld
, et al.
·
medRxiv
PDF
Show more works
View as search
Works count:
4
Citation count:
15
H-index:
2
I10-index:
1
Year
Topic
Type